CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Takeda Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Takeda Pharmaceutical Co Ltd
4F, 2-1-1, Nihombashihon-cho
Phone: +81 332782111p:+81 332782111 CHUO-KU, TKY  103-8668  Japan Ticker: 45024502
Business Summary
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20243/31/2024YesYes-YesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2835 In vitro and in vivo diagnostic substances
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of Board of Directors, Independent Director MasamiIijima 73 6/29/2022 6/1/2021
President, Chief Executive Officer, Representative Director ChristopheWeber 57 4/1/2015 6/27/2014
Chief Financial Officer, Director MilanoFuruta 56 6/26/2024 4/1/2024
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
TAKEDA UK LIMITED 1 KINGDOM STREET LONDON UK
TAKEDA IRELAND LIMITED BRAY BUSINESS PARK KILRUDDERY IE
Jerini AG 5 Riverwalk Dublin Ireland
36 additional Subsidiary records available in full report.

Business Names
Business Name
"Shire Human Genetic Therapies, Inc.
0A87
0RN3
96 additional Business Names available in full report.

General Information
Number of Employees: 49,281 (As of 3/31/2024)
Outstanding Shares: 1,585,191,249 (As of 1/31/2025)
Shareholders: 575,272
Stock Exchange: TYO
Fax Number: +81 332782000


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 18, 2025